Invus

VC · New York (United States)

VC

Pre-Seed

Seed

AI

Fintech

Lead investor

Sign up free to access full profile and submit your pitch.

About

Invus is an evergreen equity investment firm founded in 1985, managing over $10 billion in capital. With offices in New York, Paris, and Hong Kong, Invus focuses on empowering owner-managers to transform their industries by providing the freedom to take risks, the capital to reach their goals, and the strategic advice to navigate uncharted waters. The firm emphasizes a long-term investment horizon, aiming for exponential, sustainable value creation through building sustainable competitive advantages and innovating to fulfill real customer needs. Invus operates with a unique structure that allows flexibility in the types of companies and situations they engage with, fully aligning their incentives with their partners and demonstrating a long-term commitment to see through any challenges along the way. Since its inception, Invus has been successfully empowering owner-managers, with its source of capital being a European family group through their Artal investment vehicle. This evergreen structure has enabled Invus to compound its initial pool of capital over four decades, growing to over $10 billion even after distributing billions to shareholders.

Investment Criteria

Other investors that have backed the same portfolio companies as Invus. Expand any entry to see the shared portfolio companies.

• ARCH Venture Partners

  21 shared

  Shared portfolio companies

  • Autobahn Therapeutics, Inc.
  • Boundless Bio, Inc.
  • City Therapeutics, Inc.
  • eGenesis, Inc.
  • Erasca, Inc.
  • Gossamer Bio, Inc.
  • KSQ Therapeutics, Inc.
  • Kura Oncology, Inc.
  • LifeMine Therapeutics, Inc.
  • Locanabio, Inc.
  • Metacrine, Inc.
  • Mirador Therapeutics, Inc.
  • Neumora Therapeutics, Inc.
  • Orbital Therapeutics, Inc.
  • Parabilis Medicines, Inc.
  • Pretzel Therapeutics, Inc.
  • Scholar Rock Holding Corporation
  • Scholar Rock, Inc.
  • Seaport Therapeutics, Inc.
  • SIRONAX
  • Syros Pharmaceuticals, Inc.
• RA Capital Management

  21 shared

  Shared portfolio companies

  • Achilles Therapeutics plc
  • Artios Pharma Limited
  • Asher Biotherapeutics, Inc.
  • Bambusa Therapeutics Inc.
  • Bicara Therapeutics Inc.
  • Boundless Bio, Inc.
  • Bright Peak Therapeutics AG
  • Convergent Therapeutics, Inc.
  • Crinetics Pharmaceuticals, Inc.
  • Edgewise Therapeutics, Inc.
  • Hemab ApS
  • Immunic, Inc.
  • Iteos Therapeutics S.A.
  • Lexeo Therapeutics, Inc.
  • Locanabio, Inc.
  • Moderna, Inc.
  • NiKang Therapeutics, Inc.
  • Parabilis Medicines, Inc.
  • Rani Therapeutics Holdings, Inc.
  • Solid Biosciences Inc.
  • Taysha Gene Therapies, Inc.
• OrbiMed

  18 shared

  Shared portfolio companies

  • Achilles Therapeutics plc
  • ADARx Pharmaceuticals, Inc.
  • Alterome Therapeutics, Inc.
  • Averna Therapeutics Inc.
  • Convergent Therapeutics, Inc.
  • Crinetics Pharmaceuticals, Inc.
  • Cullinan Therapeutics, Inc.
  • Edgewise Therapeutics, Inc.
  • Erasca, Inc.
  • Evox Therapeutics Limited
  • Mirador Therapeutics, Inc.
  • ORIC Pharmaceuticals, Inc.
  • Ottimo Pharma Limited
  • Scorpion Therapeutics, Inc.
  • TigerConnect, Inc.
  • Triveni Bio, Inc.
  • Vicore Pharma Holding AB (publ)
  • Whitehawk Therapeutics, Inc.
• GV

  15 shared

  Shared portfolio companies

  • Arcus Biosciences, Inc.
  • Boundless Bio, Inc.
  • Cardurion Pharmaceuticals, Inc.
  • Evox Therapeutics Limited
  • Gritstone bio, Inc.
  • LendUp Loans, LLC
  • Leyden Laboratories B.V.
  • LifeMine Therapeutics, Inc.
  • Locanabio, Inc.
  • PACT Pharma, Inc.
  • Parabilis Medicines, Inc.
  • Rani Therapeutics Holdings, Inc.
  • Schrödinger, Inc.
  • SQZ Biotechnologies Company
  • Taysha Gene Therapies, Inc.
• Polaris Partners

  15 shared

  Shared portfolio companies

  • Cardurion Pharmaceuticals, Inc.
  • Cyclerion Therapeutics, Inc.
  • eGenesis, Inc.
  • Engine Biosciences Pte. Ltd.
  • Gossamer Bio, Inc.
  • Ironwood Pharmaceuticals, Inc.
  • KSQ Therapeutics, Inc.
  • Lyndra Therapeutics, Inc.
  • Metacrine, Inc.
  • Neumora Therapeutics, Inc.
  • Noema Pharma AG
  • Scholar Rock Holding Corporation
  • Scholar Rock, Inc.
  • SQZ Biotechnologies Company
  • Syros Pharmaceuticals, Inc.
• Sofinnova Partners

  13 shared

  Shared portfolio companies

  • ABIVAX Société Anonyme
  • Artios Pharma Limited
  • GenSight Biologics S.A.
  • Hemab ApS
  • Hookipa Biotech AG
  • HOOKIPA Pharma Inc.
  • Inotrem S.A
  • Inventiva S.A.
  • Noema Pharma AG
  • One Biosciences SAS
  • ProQR Therapeutics N.V.
  • Redx Pharma Ltd
  • Sensorion SA
• New Enterprise Associates

  11 shared

  Shared portfolio companies

  • Amicus Therapeutics, Inc.
  • Black Diamond Therapeutics, Inc.
  • Cardurion Pharmaceuticals, Inc.
  • Gossamer Bio, Inc.
  • Inventiva S.A.
  • Korro Bio, Inc.
  • Lexicon Pharmaceuticals, Inc.
  • Metacrine, Inc.
  • ORIC Pharmaceuticals, Inc.
  • Sagimet Biosciences Inc.
  • Senti Biosciences, Inc.
• HBM Partners AG

  10 shared

  Shared portfolio companies

  • ADARx Pharmaceuticals, Inc.
  • Ambrx, Inc.
  • eGenesis, Inc.
  • Genalyte, Inc.
  • HOOKIPA Pharma Inc.
  • NiKang Therapeutics, Inc.
  • Parabilis Medicines, Inc.
  • Valo Health, Inc.
  • Vascular Dynamics, Inc.
  • Vicore Pharma Holding AB (publ)
• Perceptive Advisors

  10 shared

  Shared portfolio companies

  • Achilles Therapeutics plc
  • Amicus Therapeutics, Inc.
  • Crinetics Pharmaceuticals, Inc.
  • Edgewise Therapeutics, Inc.
  • Endeavor BioMedicines, Inc.
  • Inventiva S.A.
  • Nanobiotix S.A.
  • NiKang Therapeutics, Inc.
  • Solid Biosciences Inc.
  • Taysha Gene Therapies, Inc.
• Flagship Pioneering

  9 shared

  Shared portfolio companies

  • Kaleido Biosciences, Inc.
  • KSQ Therapeutics, Inc.
  • LARONDE, Inc.
  • Moderna, Inc.
  • Omega Therapeutics, Inc.
  • Repertoire Immune Medicines, Inc.
  • Ring Therapeutics, Inc.
  • Syros Pharmaceuticals, Inc.
  • Valo Health, Inc.